https://www.zonebourse.com/cours/action/ARIAD-PHARMACEUTICALS-INC-8419/actualite/Ariad-Pharmaceuticals-annonce-le-debut-de-son-essai-de-dosage-de-phase-II-d-Iclusig-ponatinib-19623976/?utm_source=telegram&utm_medium=social&utm_campaign=share